Changeflow GovPing Healthcare & Life Sciences Boehringer Ingelheim EP4039300A1 Nebulizer Patent
Routine Rule Added Final

Boehringer Ingelheim EP4039300A1 Nebulizer Patent

Favicon for changeflow.com EPO Patent Bulletin - Medical Devices (A61M)
Published
Detected
Email

Summary

The EPO published patent application EP4039300A1 for a nebulizer and reservoir, filed by Boehringer Ingelheim International GmbH, designating 37 European states including all EU member states. The patent, classified under IPC A61M 15/00 and B05B 11/00, names inventors Eicher and Von Schuckmann and was granted on April 15, 2026. Patent holders gain enforceable intellectual property rights in all designated states, which may affect competitors developing similar inhalation drug delivery systems.

Published by EPO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors EPO Patent Bulletin - Medical Devices (A61M) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 44 changes logged to date.

What changed

The EPO published European patent application EP4039300A1 for a nebulizer and reservoir system, filed by Boehringer Ingelheim International GmbH, with inventors Joachim Carl Herbert Eicher and Alfred Von Schuckmann. The patent is classified under IPC codes A61M 15/00 (nebulizers) and B05B 11/00 (spraying apparatus), designating 37 European states including all EU member states, Norway, Switzerland, Turkey, and other participating states.

Competitors developing nebulizer or inhalation drug delivery systems in designated European states should review the patent claims to assess potential overlap with existing or planned products. Freedom-to-operate analysis for the European market may require evaluation of EP4039300A1 alongside other A61M-class patents.

Archived snapshot

Apr 24, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← EPO Patent Bulletin

NEBULIZER AND RESERVOIR

Publication EP4039300A1 Kind: A1 Apr 15, 2026

Applicants

Boehringer Ingelheim International GmbH

Inventors

EICHER, Joachim Carl Herbert, VON SCHUCKMANN, Alfred

IPC Classifications

A61M 15/00 20060101AFI20220614BHEP B05B 11/00 20060101ALI20220614BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Get daily alerts for EPO Patent Bulletin - Medical Devices (A61M)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EPO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
EPO
Published
April 15th, 2026
Instrument
Rule
Branch
Executive
Legal weight
Binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Medical device makers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Patent registration Medical devices
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Medical Devices Healthcare

Get alerts for this source

We'll email you when EPO Patent Bulletin - Medical Devices (A61M) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!